Antiretroviral Hydrophobic Core Graft-Copolymer Nanoparticles: The Effectiveness against Mutant HIV-1 Strains and in Vivo Distribution after Topical Application

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Pharmaceutical Research

• Publication date

  2019-03-27

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s11095-019-2604-9PMID 30919089PMCID PMC6822620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents.

  2018cited by this paper
• Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation.

  2018cited by this paper
• HIV Preexposure Prophylaxis: A Review

  2018cited by this paper
• Polymeric mixed micelles as nanomedicines: Achievements and perspectives.

  2017cited by this paper
• Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission

  2017cited by this paper
• From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

  2017cited by this paper
• Rapid Detection of Common HIV-1 Drug Resistance Mutations by Use of High-Resolution Melting Analysis and Unlabeled Probes

  2016cited by this paper
• Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity.

  2016cited by this paper
• Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model

  2016cited by this paper
• Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.

  2016cited by this paper
• PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

  2016cited by this paper
• Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.

  2015cited by this paper
• Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.

  2015cited by this paper
• The Combined Anti-HIV-1 Activities of Emtricitabine and Tenofovir plus the Integrase Inhibitor Elvitegravir or Raltegravir Show High Levels of Synergy In Vitro

  2014cited by this paper
• Gold Nanoparticles Stabilized with MPEG-Grafted Poly(l-lysine): in Vitro and in Vivo Evaluation of a Potential Theranostic Agent

  2014cited by this paper
• Nanoparticle-based drug delivery to the vagina: a review.

  2014cited by this paper
• HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

  2014cited by this paper
• Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

  2013cited by this paper
• Protected Graft Copolymer Excipient Leads to a Higher Acute Maximum Tolerated Dose and Extends Residence Time of Vasoactive Intestinal Peptide Significantly Better than Sterically Stabilized Micelles

  2013cited by this paper
• HIV-infected T cells are migratory vehicles for viral dissemination

  2012cited by this paper
• Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.

  2012cited by this paper
• Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.

  2012cited by this paper
• Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs

  2012cited by this paper
• Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus

  2012cited by this paper
• Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles.

  2011cited by this paper
• Protected Graft Copolymer (PGC) Basal Formulation of Insulin as Potentially Safer Alternative to Lantus® (Insulin-Glargine): A Streptozotocin-Induced, Diabetic Sprague Dawley Rats Study

  2011cited by this paper
• Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example

  2011cited by this paper
• Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

  2010cited by this paper
• HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model

  2010cited by this paper
• Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].

  2010cited by this paper
• PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.

  2010cited by this paper
• Assessing Reproductive Status/Stages in Mice

  2009cited by this paper
• BMC Infectious Diseases BioMed Central Research article Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

  2009cited by this paper
• Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV.

  2009cited by this paper
• Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles

  2009cited by this paper
• Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.

  2009cited by this paper
• Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor

  2009cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• HIV-1 integrase: a target for new AIDS chemotherapeutics.

  2004cited by this paper
• Novel inhibitors of HIV-1 integration.

  2004cited by this paper
• Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation

  2001cited by this paper
• HIV-1: fifteen proteins and an RNA.

  1998cited by this paper
• The retroviral enzymes.

  1994cited by this paper
• Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

  1993cited by this paper
• Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

  1991cited by this paper

• An in-depth analysis of novel combinatorial drug therapy via nanocarriers against HIV/AIDS infection and their clinical perspectives: a systematic review

  2021cites this paper
• Women-specific routes of administration for drugs: a critical overview.

  2021cites this paper
• Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections

  2020cites this paper
• Nanotechnology in reproductive medicine: Opportunities for clinical translation

  2020cites this paper